NRC NASDAQ
NRC Health
1W: +4.0%
1M: +1.7%
3M: -9.6%
YTD: +32.4%
1Y: +33.4%
3Y: -48.0%
5Y: -57.1%
$20.35
-0.97 (-4.55%)
Weekly Expected Move ±6.9%
$18
$19
$20
$22
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.45
Bullish
1 bullish
1 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (34)
Driscoll named one of three children’s hospitals nationwide recognized for excellence in patient-centered care
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
Record Backlog Powers NRC Health’s (NRC) Upward Potential
Top Stock Reports for SpaceX, Arista Networks & Boeing
Top Stock Reports for SpaceX, Arista Networks & Boeing
NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
National Research declares $0.16 dividend
NRC Health expects ~40% effective tax rate in H2 while noting 60% pipeline growth
90,182 Shares in National Research Corporation $NRC Bought by Fifth Third Bancorp
NRC Health's Q1 Earnings Fall Y/Y Due to Elevated Operating Costs
NRC Health outlines path back to low-30s EBITDA margin while targeting $1M-$1.5M quarterly CapEx
National Research Non-GAAP EPS of $0.21, revenue of $34.8M
National Research (NASDAQ:NRC) Stock Crosses Above 200 Day Moving Average – Time to Sell?
National Research NRC Q4 2025 Earnings Transcript
National Research (NASDAQ:NRC) Share Price Passes Above 200 Day Moving Average – Time to Sell?
NRC Health Surges 62% in a Year: Should You Buy the Stock?
National Research (NASDAQ:NRC) Shares Pass Above 200-Day Moving Average – Here’s What Happened
National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average – What’s Next?
National Research (NASDAQ:NRC) Stock Passes Above Two Hundred Day Moving Average – Here’s Why
The Zacks Analyst Blog Oracle, T-Mobile, Gilead, and C&F Financial
Top Stock Reports for Oracle, T-Mobile & Gilead
National Research (NASDAQ:NRC) Shares Pass Above 200 Day Moving Average – Time to Sell?
NRC falls after announcing $60 million share repurchase program
Top 10 healthcare stocks with highest dividend yield amid volatile markets
NRC Health says total recurring contract value exceeds $152 million
NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27%
NRC Health Named #1 Best in KLAS Again for Healthcare Experience Management
National Research Corporation (NRC) Q4 2025 Earnings Call Prepared Remarks Transcript
NRC Health Announces Fourth Quarter 2025 Results
Nations Royalty Announces CEO Transition
National Research: The Turnaround Is Invisible Until It Isn't
Nations Royalty Announces AGSM Results
NRC Health Partners with Mosaic Life Care to Advance Patient Experience Across the Midwest
NRC Health Appoints David Burik as Executive Vice President, Strategic Insights